Choon Hee Chung Selected Research

prolyl T RNA synthetase

1/2024

DWN12088, A Prolyl-tRNA Synthetase Inhibitor, Alleviates Hepatic Injury in Nonalcoholic Steatohepatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Choon Hee Chung Research Topics

Disease

43	Type 2 Diabetes Mellitus (MODY) 05/2024 - 07/2006
23	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 02/2004
22	Insulin Resistance 04/2023 - 02/2007
15	Inflammation (Inflammations) 03/2024 - 06/2005
13	Albuminuria 01/2021 - 10/2007
10	Obesity 05/2024 - 09/2013
8	Non-alcoholic Fatty Liver Disease 03/2024 - 01/2009
8	Body Weight (Weight, Body) 01/2023 - 01/2006
6	Hypertension (High Blood Pressure) 10/2023 - 10/2011
6	Fibrosis (Cirrhosis) 01/2023 - 01/2015
6	Neoplasms (Cancer) 10/2021 - 06/2005
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2015 - 01/2009
4	Proteinuria 01/2015 - 02/2004
3	Dyslipidemias (Dyslipidemia) 05/2024 - 09/2013
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2015
3	Diabetes Mellitus 01/2023 - 02/2012
3	Weight Gain 11/2022 - 01/2014
3	Kidney Diseases (Kidney Disease) 01/2019 - 11/2012
3	Hypoglycemia (Reactive Hypoglycemia) 05/2016 - 02/2004
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2015 - 06/2011
2	Drug-Related Side Effects and Adverse Reactions 05/2024 - 11/2023
2	Fatty Liver 01/2023 - 10/2012
2	Peripheral Nervous System Diseases (PNS Diseases) 11/2022 - 01/2022
2	Adenoma (Adenomas) 10/2022 - 10/2021
2	Cushing Syndrome 10/2022 - 10/2021
2	Wounds and Injuries (Trauma) 01/2022 - 01/2021
2	Glucose Intolerance 01/2018 - 01/2015
2	Sarcopenia 07/2015 - 01/2015
2	Hyperinsulinism (Hyperinsulinemia) 09/2013 - 02/2004
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2024
1	Idiopathic Pulmonary Fibrosis 01/2024
1	Hypokalemia 10/2023

Drug/Important Bio-Agent (IBA)

20	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2006
12	LipidsIBA 04/2023 - 01/2006
11	Metformin (Glucophage)FDA LinkGeneric 05/2024 - 02/2007
11	Insulin (Novolin)FDA Link 01/2020 - 02/2004
8	Triglycerides (Triacylglycerol)IBA 03/2024 - 02/2006
8	CreatinineIBA 01/2021 - 02/2009
8	AlbuminsIBA 01/2021 - 02/2009
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 02/2004
6	CurcuminIBA 01/2023 - 05/2016
5	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2006
5	AntioxidantsIBA 01/2019 - 06/2011
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2006
4	lobeglitazoneIBA 11/2022 - 01/2014
4	Proteins (Proteins, Gene)FDA Link 12/2020 - 01/2009
4	AdiponectinIBA 01/2017 - 01/2009
3	4- (3- amino- 4- (2,4,5- trifluorophenyl)butanoyl)- 3- (tert- butoxymethyl)piperazin- 2- oneIBA 11/2023 - 01/2017
3	HDL CholesterolIBA 01/2023 - 01/2009
3	ThiazolidinedionesIBA 11/2022 - 04/2007
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 02/2012
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2021 - 07/2009
3	CytokinesIBA 01/2021 - 06/2005
3	Therapeutic UsesIBA 01/2019 - 12/2011
3	Sitagliptin Phosphate (Januvia)FDA Link 10/2018 - 01/2017
3	ORALIT (ORS)IBA 01/2017 - 10/2011
3	CC ChemokinesIBA 01/2017 - 07/2013
3	Angiotensin Receptor AntagonistsIBA 10/2016 - 02/2004
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2014 - 10/2012
3	C-Reactive ProteinIBA 10/2011 - 01/2009
2	oxidized low density lipoproteinIBA 05/2024 - 10/2020
2	Chemokine ReceptorsIBA 03/2024 - 01/2018
2	dapagliflozinIBA 11/2023 - 01/2023
2	glimepiride (Amarel)FDA LinkGeneric 01/2023 - 02/2007
2	GlucocorticoidsIBA 01/2023 - 02/2004
2	anagliptinIBA 01/2023 - 01/2015
2	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 01/2021
2	AMP-Activated Protein KinasesIBA 01/2023 - 03/2015
2	vactosertibIBA 01/2023 - 01/2022
2	EnzymesIBA 01/2021 - 05/2009
2	NADP (NADPH)IBA 01/2021 - 02/2009
2	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2020 - 02/2009
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 11/2012
2	Angiotensin IIIBA 01/2019 - 02/2004
2	Biomarkers (Surrogate Marker)IBA 03/2018 - 01/2014
2	LC15-0444IBA 01/2018 - 01/2017
2	2,4-thiazolidinedione (thiazolidinedione)IBA 10/2017 - 04/2007
2	Pioglitazone (Actos)FDA Link 04/2017 - 12/2008
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2016 - 01/2015
2	SodiumIBA 07/2015 - 01/2015
2	Uric Acid (Urate)IBA 07/2015 - 09/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 02/2007
2	nephrinIBA 07/2013 - 11/2012
2	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 03/2013 - 05/2009
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 05/2009 - 01/2009
2	Rosiglitazone (Avandia)FDA Link 12/2008 - 02/2007
2	AdipokinesIBA 09/2007 - 02/2007
1	Atorvastatin (Lipitor)FDA Link 05/2024
1	C-PeptideIBA 05/2024
1	recoflavoneIBA 03/2024
1	eupatilinIBA 03/2024
1	Indicators and Reagents (Reagents)IBA 01/2024
1	prolyl T RNA synthetaseIBA 01/2024
1	CollagenIBA 01/2024
1	AldosteroneIBA 10/2023
1	lipoprotein cholesterolIBA 01/2023
1	Drug CombinationsIBA 01/2023

Therapy/Procedure

13	Therapeutics 05/2024 - 02/2014
3	Glycemic Control 01/2023 - 01/2015
2	Aftercare (After-Treatment) 01/2018 - 06/2015